MaxCyte

Presence

MaxCyte is owned by Casi Pharmaceuticals.

Casi Pharmaceuticals is a company listed under the stock ticker CASI (US).

Casi Pharmaceuticals has a direct presence in 2 countries.

They are in:

Executives

View the org chart displaying its 29 main executives

Most searched biographies at MaxCyte
Popular executive movements at MaxCyte
  • Cenk Sumen, Chief Scientific Officer, has left the company  (posted on January 29 2024).
  • Maher Masoud who is Executive Vice President, Head of Global Business Development and Chief Counsel, will be promoted to President and Chief Executive Officer on Jan. 1, 2024  (posted on December 12 2023).
  • Doug Doerfler, Director, President and Chief Executive Officer, will leave the company on Jan. 1, 2024  (posted on December 12 2023).

Click here to view some more movements at MaxCyte

Create your alert
to follow the executive moves at MaxCyte.

Biotechnology

Casi Pharmaceuticals has 2,281 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology
Popular contacts in Biotechnology

Learn more about the Biotechnology industry >

News

Press releases by MaxCyte
Social media about MaxCyte

Get in Touch

Contact by email its executives including Maher Masoud Premium

Call MaxCyte at +1 301...

View the org chart

Register to receive your alert

Report an error

The best decision-maker directory

Companies

Companies

Discover the organization charts of your favorite companies.

Executives

Executives

Spot the influential executives using our search tools.

Alerts

Alerts

Receive notifications when executive positions change.

Customers

Real-time

Fuel your company's success with our real-time data.

Individual Access Executive Data Sets
Executives
Companies
The Official Board